Feed VINC
VI
Vincerx Pharma, Inc. VINC · OTC
$0.02 -41.63% (-$0.01)
Summary
38 / 100 · Bulios Score
Valuation 100Growth 0Profitability 0Quality 3Debt 96Stability 39
What speaks for it
- It has no debt and holds $4.44M in cash.
What to watch
- The company made a loss over the last 12 months.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
2020202120222023202420252026
Diluted EPS (USD)
2020202120222023202420252026
- Analyst estimate
There is not enough revenue history yet to say how fast it grows.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $22.6M.
Profitability in detailIs it financially healthy?
YesCash and short-term investments $4.44M
Debt $0.00
Free cash flow over 12 months -$22.8M
It has no debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 7
- Hold 0
- Sell 0
Today's price within the analysts' price targets
Today's price $0.015 Average target $3
$0.015 $4
The average target of $3 is 19,900% above today's price. 100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.